Finsbury Worldwide Pharm Tst PLC
05 July 2006
BLOCKLISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically.
To: The FSA
Date: 5 JULY 2006
1. Name of applicant:
FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC
2. Name of scheme
GENERAL BLOCKLISTING
3. Period of return:
From 5 JANUARY 2006 To 5 JULY 2006
4. Balance under scheme from previous return:
594,574
5. The amount by which the block scheme has been increased, if the scheme has
been increased since the date of the last return
SUBSEQUENT GENERAL BLOCK LISTING - 2,871,108 ORDINARY SHARES (25 APRIL 2006)
6. Number of securities issued/allotted under scheme during period:
744,574 ORDINARY SHARES
7 Balance under scheme not yet issued/allotted at end of period
2,721,108
8. Number and class of securities originally listed and the date of admission
2,729,574 ORDINARY SHARES, 29 JUNE 2005
9. Total number of securities in issue at the end of the period
57,572,150 ORDINARY SHARES
Name of contact TRACEY LAGO
Address of contact 10 CROWN PLACE, LONDON, EC2A 4FT
Telephone number of contact 020 7426 6219
Signed by Company Secretary, for and on behalf of
FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC
If you knowingly or recklessly give false or misleading information you may be
liable to prosecution.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.